Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new ...
Dr Bradley Gaynes discusses how cultural context can shape anxiety symptoms, diagnosis, and treatment engagement among ...
Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...
(Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and ...
Anxiety is a significant feature of mental health conditions besides generalized anxiety disorder, marked by a state of persistent worry and apprehension. Perhaps most prominently, anxiety is a ...
In a world of constant connectivity and mounting pressures, generalized anxiety disorder (GAD) has emerged as a significant mental health challenge affecting millions. Recent studies show that anxiety ...
Anxiety disorders are common but often missed in primary care, and routine screening, cognitive-behavioral therapy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results